Personal information

Websites & social links

Burkard Lab

Other IDs

Scopus Author ID: 7003513820

Keywords

Plk1, mitosis breast cancer, kinetochore, cell division, aneuploidy, cancer

Countries

United States

Biography

Research interests: mitotic regulation, chromosomal instability, drug mechanisms, kinetochore signaling, super-resolution microscopy, NGS, predictive biomarkers for breast cancer, clinical trials.

Activities

Collapse all

Employment (4)

University of Iowa Holden Comprehensive Cancer Center: Iowa City, US

2024-10-01 to present | Director, Holden Comprehensive Cancer Center (Internal Medicine)
Employment
Source: Self-asserted source
Mark E. Burkard

University of Wisconsin–Madison: Madison, Wisconsin, US

2019-07-01 to 2024-09-24 | Professor (Medicine, Oncology)
Employment
Source: Self-asserted source
Mark E. Burkard

University of Wisconsin-Madison: Madison, WI, US

2015-07-01 to 2019-06-30 | Associate Professor (Medicine--Hematology/Oncology)
Employment
Source: Self-asserted source
Mark E. Burkard

University of Wisconsin Madison: Madison, WI, US

2008-07-01 to 2015-06-30 | Assistant Professor (Medicine--Hematology/Oncology)
Employment
Source: Self-asserted source
Mark E. Burkard

Education and qualifications (5)

Memorial Sloan-Kettering Cancer Center: New York, NY, US

2004-07-01 to 2008-06-30 | Medical Oncology (Medicine)
Education
Source: Self-asserted source
Mark E. Burkard

NewYork-Presbyterian Hospital/Weill Cornell Medical Center: New York, NY, US

2002-06-21 to 2004-06-30 | Resident (Medicine)
Education
Source: Self-asserted source
Mark E. Burkard

University of Rochester: Rochester, NY, US

1994-08-01 to 2002-05-31 | MD (School of Medicine)
Education
Source: Self-asserted source
Mark E. Burkard

University of Rochester: Rochester, New York, US

1996-07-01 to 2001-05-31 | PhD (Chemistry)
Education
Source: Self-asserted source
Mark E. Burkard

University at Buffalo - The State University of New York: Buffalo, NY, US

1990-08-15 to 1994-05-15 | BS (Mathematical Physics)
Education
Source: Self-asserted source
Mark E. Burkard

Professional activities (1)

University of Wisconsin–Madison: Madison, Wisconsin, US

2021-07-01 | Mary and Rob Gooze Chair (Medicine)
Distinction
Source: Self-asserted source
Mark E. Burkard

Funding (8)

Integrated Training For Physician-Scientists

2021-07-01 to 2026-06-30 | Grant
National Institute of General Medical Sciences (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.9734621
GRANT_NUMBER: T32GM140935
Source: Self-asserted source
Mark E. Burkard via DimensionsWizard

Mechanisms of Plk1 at the mitotic centromere

2021-04-01 to 2025-03-31 | Grant
National Institute of General Medical Sciences (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.9644104
GRANT_NUMBER: R01GM141068
Source: Self-asserted source
Mark E. Burkard via DimensionsWizard

Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer

2018-12-07 to 2023-11-30 | Grant
National Cancer Institute (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.7909731
GRANT_NUMBER: R01CA234904
Source: Self-asserted source
Mark E. Burkard via DimensionsWizard

NRSA Training Core

2017-09-21 to 2022-06-30 | Grant
National Center for Advancing Translational Sciences (Rockville, US)
URL: https://app.dimensions.ai/details/grant/grant.7072793
GRANT_NUMBER: TL1TR002375
Source: Self-asserted source
Mark E. Burkard via DimensionsWizard

Chromosomal Instability as a Determinant of Paclitaxel Sensitivity in Breast Cancer

2016-03-01 to 2019-02-28 | Grant
Congressionally Directed Medical Research Programs (Frederick, US)
URL: https://app.dimensions.ai/details/grant/grant.7137242
GRANT_NUMBER:

W81XWH-16-1-0050
Source: Self-asserted source
Mark E. Burkard via DimensionsWizard

Burkard, Mark -- A chemical-genetic library of human cell lines for evaluating pharmacologic inhibition of protein kinases

2014-09-01 to 2019-08-31 | Grant
Burroughs Wellcome Fund (Durham, US)
URL: https://app.dimensions.ai/details/grant/grant.100082681
GRANT_NUMBER:

1014160
Source: Self-asserted source
Mark E. Burkard via DimensionsWizard

A multiplexed in vivo device to assess optimal breast cancer therapy

2014-03 to 2017-02 | Grant
Wisconsin Partnership Program (Madison, WI, US)
GRANT_NUMBER:

2667
Source: Self-asserted source
Mark E. Burkard

Separation of late mitotic functions of polo-like kinase 1 with chemical genetics

2011-09-01 to 2016-04-30 | Grant
National Institute of General Medical Sciences (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.2521183
GRANT_NUMBER: R01GM097245
Source: Self-asserted source
Mark E. Burkard via DimensionsWizard

Peer review (22 reviews for 5 publications/grants)

Review activity for Breast cancer research and treatment. (18)
Review activity for Cancer gene therapy. (1)
Review activity for EMBO molecular medicine. (1)
Review activity for EMBO reports. (1)
Review activity for Journal for immunotherapy of cancer. (1)
How many people are using ORCID?